Videos

Are You Worried About HER2+ Breast Cancer Recurrence?

April 4th 2025, 4:54am

Breaking Down Kidney Cancer Treatment Advancements and Providing Hope

April 3rd 2025, 8:00pm

Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.

The Benefit of Clinical Trial Enrollment for Patients With Cancer

April 2nd 2025, 8:00pm

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.

NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery

April 2nd 2025, 1:00pm

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.

Raising Awareness of Financial Struggles Faced by AYA Cancer Survivors

April 1st 2025, 8:00pm

Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.

Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care

March 31st 2025, 9:00pm

CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.

Research Shines Light on Disparities Across Breast Cancer Care

March 29th 2025, 2:00pm

Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these challenges.

Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis

March 28th 2025, 7:11pm

CURE spoke with Leslie Waltke about the importance of physical therapy during a cancer journey.

Clinical Trial to Evaluate Opdivo, Opdualag in Glioblastoma

March 27th 2025, 8:53pm

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer

March 27th 2025, 1:00pm

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study.